John Malloy
General Partner & Founder @ BlueRun Ventures
Menlo Park, United States
John Malloy is a Series A investor at BlueRun Ventures in Menlo Park focused on Software and Internet. John Malloy, the Partner, co-founded BlueRun Ventures and is based in Menlo Park. John has successfully invested in a broad spectrum of technologies and services. John focuses on software and services opportunities across Internet, Media, and Mobile. John was an early investor in PayPal, Waze, Topsy, and Slide. Prior to starting the firm, Johnspent more than 15 years in management and executive roles at Nokia, MCI, and a communications services start-up. He holds a J.D. from George Mason School of Law and a B.A. from Boston College.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries John Malloy invests in
Stages John Malloy invests in
Countries John Malloy invests in
Investment Focus
Industry
- Software 5 (17%)
- Internet 3 (10%)
- Analytics 3 (10%)
- Real Time 3 (10%)
- Art 2 (7%)
Stage
- Series A 8 (28%)
- Series B 8 (28%)
- Series C 6 (21%)
- Funding Round 3 (10%)
- Series D 2 (7%)
Country
- United States 15 (52%)
- Ireland 1 (3%)
- United Kingdom 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Obvlo
|
Obvlo is an InfoTech firm that allows visitors to discover local restaurants, tourism sites, and events through apps or web-based platforms. | Seed / Jan 01, 2023 | |
CIONIC
|
CIONIC is a technology company that builds a platform for human augmentation that powers people to transcend physical limitations. The company develops wearable solutions that provide comprehensive analysis and precise augmentation to improve human performance and improve quality of life. Their devices push the limits of integrated hardware,software, and algorithms, emphasizing functional wearability and personalized intelligence. | $12.5M / Series A / Sep 28, 2022 | |
Hello Heart
|
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to useand helps participants improve their heart health in a fun and engaging way. | $70M / Series D / May 02, 2022 | |
alwaysAI
|
alwaysAI enables businesses everywhere to boost their operations with the incredible power of computer vision (CV). With alwaysAI, they can build, deploy, run and manage CV applications across a vast array of IoT devices, including existing camera infrastructure. CV provides powerful real-time insights to better serve customers and immediatelyimprove operational efficiencies. Transform your business today with alwaysAI. | $7M / Series B / Feb 22, 2022 | |
|
Hello Heart
|
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to useand helps participants improve their heart health in a fun and engaging way. | $45M / Series C / May 26, 2021 | |
|
alwaysAI
|
alwaysAI enables businesses everywhere to boost their operations with the incredible power of computer vision (CV). With alwaysAI, they can build, deploy, run and manage CV applications across a vast array of IoT devices, including existing camera infrastructure. CV provides powerful real-time insights to better serve customers and immediatelyimprove operational efficiencies. Transform your business today with alwaysAI. | $5M / Series A / Jan 15, 2021 | |
Human API
|
Human API is a real-time health data network that gives consumers a simple way to view and share their health data from everywhere - regardless of how or where that data was collected, processed, or stored. The company provides a single, secure connection to data from 90% of US hospitals, electronic medical records, pharmacies, and labs, along with300+ wearable devices and wellness apps. Consumers are in full control of what companies they share their health data with, and companies have one easy way to access fragmented health data sources.It was founded in 2013 and is based in San Mateo, California. | $20M / Series C / Oct 27, 2020 | |
Kitman Labs
|
Kitman Labs is a sports analytics company that uses artificial intelligence to increase athlete performance and health. It is driven by a mission is to enable the sports team to win by increasing player availability through injury reduction. The company believes that winning has as much to do with science as it does with desire. By accuratelycapturing relevant athlete data and applying algorithms grounded in scientific research, Kitman's products and services provide actionable insights that improve player availability and deliver stronger team results.Kitman Labs is the only company serving the elite athlete marketplace providing accurate, marker-less motion capture and delivering real-time alerts that enable coaches and staff to take preventative actions before injuries occur. | $5.1M / Series B / Nov 17, 2019 | |
|
Hello Heart
|
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to useand helps participants improve their heart health in a fun and engaging way. | $12M / Series B / Jul 30, 2019 | |
|
Human API
|
Human API is a real-time health data network that gives consumers a simple way to view and share their health data from everywhere - regardless of how or where that data was collected, processed, or stored. The company provides a single, secure connection to data from 90% of US hospitals, electronic medical records, pharmacies, and labs, along with300+ wearable devices and wellness apps. Consumers are in full control of what companies they share their health data with, and companies have one easy way to access fragmented health data sources.It was founded in 2013 and is based in San Mateo, California. | $10M / Series B / Feb 11, 2019 | |
| See all 29 investments → | |||
Co-Investors
About BlueRun Ventures
BlueRun Ventures is a venture capital firm with offices in the United States, Shanghai, Beijing, and Korea. BlueRun invests in information technology, mobile, and consumer technologies, with an emphasis on mobile opportunities. BRV has invested in over 160 companies, with select exits from PayPal (acquired by eBay), Waze (acquired by Google),Topsy (acquired by Apple), Coupa (NASDAQ: COUP), and more. In 2005, BlueRun changed its name from Nokia Venture Partners. While branded as Nokia Venture Partners, the firm helped to build emerging market leaders such as Airgo, Bitfone, Cornice, PayPal, Wavemarket, and WiderThan.
BlueRun Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
John Malloy
General Partner & Founder
|
|||
Jonathan Ebinger
General Partner
|
|||
Jui Tan
Partner
|
|||
Kwan Yoon
Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does John Malloy invest in?
John Malloy invests primarily in Software, Internet and Analytics startups, most often at Series A and Series B stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did John Malloy last invest?
The most recent investment recorded for John Malloy closed in Jan 2023. Shizune tracks 29 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
